NASHVILLE, Tenn. , Feb. 4, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) , a specialty pharmaceutical company focused on developing new products for rare diseases, announced...
NASHVILLE, Tenn. , Dec. 8, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), today announced an important update regarding its Caldolor ® (ibuprofen) Injection. The product's...
NASHVILLE, Tenn. , Nov. 4, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) , a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved...
NASHVILLE, Tenn. , Oct. 28, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) , a specialty pharmaceutical company, announced today that it will release its third quarter 2025...
 Cumberland to expand its gastroenterology offerings with the market-leading Helicobacter pylori therapy
Premier Membership includes 4,350 U.S. Hospitals
Injectable Ibuprofen Approved for Treating Pain & Fever
Vibativ ®  treats patients with pneumonia and serious skin infections